MedPath

ABBVIE LTD

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

EMC:35
NMPA:1
EMA:1

Drug Approvals

Adalimumab Solution for Injection

Product Name
修美乐
Approval Number
S20170019
Approval Date
Aug 14, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.